110 followers
New paper is out. Aim for a tolerable #cabozantinib exposure rather than maximum exposure in patients with #RCC. A starting dose of 40 mg will most likely result in a tolerable exposure. Tips for fine-tuning in our practical algorithm https://t.co/46Vyp0JJ